Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia.
Saved in:
| Title: | Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia. |
|---|---|
| Authors: | Bonifazi A; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Ellenberger M; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Farino ZJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Aslanoglou D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Rais R; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD., Pereira S; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Physiology, University of Toronto, Toronto, Ontario, Canada., Mantilla-Rivas JO; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA., Boateng CA; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Eshleman AJ; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR., Janowsky A; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR.; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR., Hahn MK; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Banting & Best Diabetes Centre, Toronto, Ontario, Canada., Schwartz GJ; The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, NY.; Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY., Slusher BS; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD., Newman AH; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD., Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA. |
| Source: | Diabetes [Diabetes] 2024 Sep 01; Vol. 73 (9), pp. 1411-1425. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38869519 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bonifazi+A%22">Bonifazi A</searchLink>; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Ellenberger+M%22">Ellenberger M</searchLink>; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Farino+ZJ%22">Farino ZJ</searchLink>; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Aslanoglou+D%22">Aslanoglou D</searchLink>; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Rais+R%22">Rais R</searchLink>; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Pereira+S%22">Pereira S</searchLink>; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Physiology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Mantilla-Rivas+JO%22">Mantilla-Rivas JO</searchLink>; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Boateng+CA%22">Boateng CA</searchLink>; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Eshleman+AJ%22">Eshleman AJ</searchLink>; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Janowsky+A%22">Janowsky A</searchLink>; Research Service, Veterans Affairs Portland Health Care System, Portland, OR.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR.; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Hahn+MK%22">Hahn MK</searchLink>; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Banting & Best Diabetes Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Schwartz+GJ%22">Schwartz GJ</searchLink>; The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, NY.; Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.<br /><searchLink fieldCode="AU" term="%22Slusher+BS%22">Slusher BS</searchLink>; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Newman+AH%22">Newman AH</searchLink>; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Freyberg+Z%22">Freyberg Z</searchLink>; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2024 Sep 01; Vol. 73 (9), pp. 1411-1425. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38869519 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/db24-0175 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1411 Titles: – TitleFull: Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bonifazi A – PersonEntity: Name: NameFull: Ellenberger M – PersonEntity: Name: NameFull: Farino ZJ – PersonEntity: Name: NameFull: Aslanoglou D – PersonEntity: Name: NameFull: Rais R – PersonEntity: Name: NameFull: Pereira S – PersonEntity: Name: NameFull: Mantilla-Rivas JO – PersonEntity: Name: NameFull: Boateng CA – PersonEntity: Name: NameFull: Eshleman AJ – PersonEntity: Name: NameFull: Janowsky A – PersonEntity: Name: NameFull: Hahn MK – PersonEntity: Name: NameFull: Schwartz GJ – PersonEntity: Name: NameFull: Slusher BS – PersonEntity: Name: NameFull: Newman AH – PersonEntity: Name: NameFull: Freyberg Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1939-327X Numbering: – Type: volume Value: 73 – Type: issue Value: 9 Titles: – TitleFull: Diabetes Type: main |
| ResultId | 1 |